Literature DB >> 20643091

Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.

Beate Sander1, Chris T Bauch, David Fisman, Robert A Fowler, Jeffrey C Kwong, Andreas Maetzel, Allison McGeer, Janet Raboud, Damon C Scales, Marija Zivkovic Gojovic, Murray Krahn.   

Abstract

In response to the pandemic H1N1 influenza 2009 outbreak, many jurisdictions undertook mass immunization programs that were among the largest in recent history. The objective of this study was to determine the cost-effectiveness of the mass H1N1 immunization program in Ontario, Canada's most populous province (population 13,000,000). This analysis suggests that a mass immunization program as carried out in Ontario and many other high-income health care systems in response to H1N1 2009 was effective in preventing influenza cases and health care resource use and was also highly cost-effective despite the substantial program cost. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643091     DOI: 10.1016/j.vaccine.2010.07.010

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  Pandemic (H1N1) 2009: assessing the response.

Authors:  Donald E Low; Allison McGeer
Journal:  CMAJ       Date:  2010-10-18       Impact factor: 8.262

2.  Patterns of spread of influenza A in Canada.

Authors:  Daihai He; Jonathan Dushoff; Raluca Eftimie; David J D Earn
Journal:  Proc Biol Sci       Date:  2013-09-11       Impact factor: 5.349

3.  Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2.

Authors:  Mark Roberts; Louise B Russell; A David Paltiel; Michael Chambers; Phil McEwan; Murray Krahn
Journal:  Value Health       Date:  2012 Sep-Oct       Impact factor: 5.725

4.  Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.

Authors:  Lisa A Prosser; Tara A Lavelle; Anthony E Fiore; Carolyn B Bridges; Carrie Reed; Seema Jain; Kelly M Dunham; Martin I Meltzer
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

5.  Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity.

Authors:  Maytee Cruz-Aponte; Erin C McKiernan; Marco A Herrera-Valdez
Journal:  BMC Infect Dis       Date:  2011-08-01       Impact factor: 3.090

6.  Critical care services and the H1N1 (2009) influenza epidemic in Australia and New Zealand in 2010: the impact of the second winter epidemic.

Authors:  Steven A R Webb; Cecile Aubron; Michael Bailey; Rinaldo Bellomo; Belinda Howe; Colin McArthur; Siouxzy Morrison; Ian Seppelt
Journal:  Crit Care       Date:  2011-06-09       Impact factor: 9.097

7.  Estimation of the health impact and cost-effectiveness of influenza vaccination with enhanced effectiveness in Canada.

Authors:  David N Fisman; Ashleigh R Tuite
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

8.  Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study.

Authors:  Mariana Galante; Olatz Garin; Elisa Sicuri; Francesc Cots; Anna García-Altés; Montserrat Ferrer; Àngela Dominguez; Jordi Alonso
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

Review 9.  Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics.

Authors:  Román Pérez Velasco; Naiyana Praditsitthikorn; Kamonthip Wichmann; Adun Mohara; Surachai Kotirum; Sripen Tantivess; Constanza Vallenas; Hande Harmanci; Yot Teerawattananon
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

10.  Is a Mass Prevention and Control Program for Pandemic (H1N1) 2009 Good Value for Money? Evidence from the Chinese Experience.

Authors:  Biyan Wang; Jinliang Xie; Pengqian Fang
Journal:  Iran J Public Health       Date:  2012-11-01       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.